SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030938
Filing Date
2023-11-08
Accepted
2023-11-08 16:06:12
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20230930_10q.htm   iXBRL 10-Q 787086
2 EXHIBIT 31.1 ex_588447.htm EX-31.1 11171
3 EXHIBIT 31.2 ex_588448.htm EX-31.2 11201
4 EXHIBIT 32.1 ex_588449.htm EX-32.1 4307
5 EXHIBIT 32.2 ex_588450.htm EX-32.2 4323
  Complete submission text file 0001437749-23-030938.txt   4057386

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230930.xsd EX-101.SCH 42372
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230930_def.xml EX-101.DEF 267921
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230930_lab.xml EX-101.LAB 234579
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230930_pre.xml EX-101.PRE 292628
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20230930_cal.xml EX-101.CAL 29275
54 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230930_10q_htm.xml XML 572632
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 231387805
SIC: 2836 Biological Products, (No Diagnostic Substances)